Traders sold shares of Johnson & Johnson (NYSE:JNJ) on strength during trading hours on Friday. $119.18 million flowed into the stock on the tick-up and $173.22 million flowed out of the stock on the tick-down, for a money net flow of $54.04 million out of the stock. Of all companies tracked, Johnson & Johnson had the 0th highest net out-flow for the day. Johnson & Johnson traded up $0.47 for the day and closed at $119.04

Several analysts have recently weighed in on JNJ shares. BTIG Research reiterated a “neutral” rating on shares of Johnson & Johnson in a research note on Thursday. Vetr upgraded Johnson & Johnson from a “hold” rating to a “buy” rating and set a $124.21 price target for the company in a research note on Monday, August 22nd. Deutsche Bank AG reiterated a “buy” rating and issued a $142.00 price target on shares of Johnson & Johnson in a research note on Friday, August 19th. Zacks Investment Research upgraded Johnson & Johnson from a “hold” rating to a “buy” rating and set a $139.00 price target for the company in a research note on Friday, August 5th. Finally, Jefferies Group lifted their price target on Johnson & Johnson from $113.00 to $119.00 and gave the stock a “hold” rating in a research note on Thursday, August 4th. One research analyst has rated the stock with a sell rating, eleven have given a hold rating and twelve have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $119.53.

The firm has a market cap of $325.68 billion and a PE ratio of 22.18. The stock has a 50-day moving average of $122.92 and a 200-day moving average of $114.31.

Johnson & Johnson (NYSE:JNJ) last issued its quarterly earnings data on Tuesday, July 19th. The company reported $1.74 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.68 by $0.06. The firm had revenue of $18.50 billion for the quarter, compared to the consensus estimate of $17.98 billion. Equities research analysts forecast that Johnson & Johnson will post $6.69 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 19th. Shareholders of record on Friday, August 5th were paid a dividend of $0.29 per share. This represents a $1.16 annualized dividend and a yield of 0.97%.

In other Johnson & Johnson news, CAO Ronald A. Kapusta sold 3,000 shares of the company’s stock in a transaction dated Tuesday, June 7th. The shares were sold at an average price of $115.79, for a total transaction of $347,370.00. Following the sale, the chief accounting officer now directly owns 28,725 shares of the company’s stock, valued at $3,326,067.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CAO Ronald A. Kapusta sold 2,935 shares of the company’s stock in a transaction dated Friday, July 22nd. The stock was sold at an average price of $125.01, for a total transaction of $366,904.35. Following the sale, the chief accounting officer now directly owns 28,660 shares in the company, valued at $3,582,786.60. The disclosure for this sale can be found here.

Other hedge funds have recently modified their holdings of the company. Bruni J V & Co. Co. boosted its stake in shares of Johnson & Johnson by 0.9% in the fourth quarter. Bruni J V & Co. Co. now owns 39,669 shares of the company’s stock valued at $4,075,000 after buying an additional 344 shares in the last quarter. Pettyjohn Wood & White Inc. raised its position in shares of Johnson & Johnson by 8.0% in the fourth quarter. Pettyjohn Wood & White Inc. now owns 62,194 shares of the company’s stock worth $6,389,000 after buying an additional 4,612 shares during the last quarter. Hemenway Trust Co LLC raised its position in shares of Johnson & Johnson by 1.0% in the fourth quarter. Hemenway Trust Co LLC now owns 120,822 shares of the company’s stock worth $12,411,000 after buying an additional 1,185 shares during the last quarter. Markston International LLC raised its position in shares of Johnson & Johnson by 2.1% in the fourth quarter. Markston International LLC now owns 114,331 shares of the company’s stock worth $11,744,000 after buying an additional 2,300 shares during the last quarter. Finally, Clarkston Capital Partners LLC raised its position in shares of Johnson & Johnson by 2.2% in the fourth quarter. Clarkston Capital Partners LLC now owns 300,608 shares of the company’s stock worth $30,878,000 after buying an additional 6,470 shares during the last quarter.

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company’s segments include Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women’s health and wound care markets.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.